Longitudinal patterns of predominant asthma disease activity in pediatric patients enrolled in an asthma-specific disease management program

Journal of Asthma

Volumn 45, Issue 6, 2008, Pages 501-505

  Scott, Lyne ^a,c   Nichols, Breck ^a   Choi Kwong, Kenny Yat ^a   Morphew, Tricia ^b   Jones, Craig A ^a,b  

^a LAC USC MEDICAL CENTER   (United States)

^b Southern California Chapter of the Asthma and Allergy Foundation of America   (United States)

^c General Laboratories Building   (United States)

Author keywords

Asthma; Disease activity; Inner city; Pediatric; Severity

Indexed keywords

STEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MALE; MORBIDITY; PEDIATRICS; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; SCHOOL; UNITED STATES;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES; HUMANS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 46949088764     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802085477     Document Type: Article

References (14)

1. Chipps BE, Spahn JD, Sorkness CA, et al. Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists. J Pediatr 2006; 148:517-521.
2. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM. Asthma variability in patients treated with beta2-agonists alone. J Allergy Clin Immunol 2003; 112:1088-1094.
3. Jones CA, Clement LT, Morphew T, et al.. Achieving and maintaining asthma control in an urban pediatric disease management program: The Breathmobile Program. J Allergy Clin Immunol 2007; 119:1445-1453.
4. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health; 1997. Publication 97-4051.
5. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Bethesda (MD): National Institutes of Health; 2002. Publication. 02-5074.
6. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3) Guidelines on Asthma. Bethesda (MD): National Institutes of Health; 2007.
7. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO workshop report. Bethesda (MD): National Institutes of Health, National Heart Lung and Blood Institute; 2002. NIH publication 02-3659.
8. Li, et al. Attaining optimal asthma control: A practice parameter. J Allergy Clin Immunol 2005; 116(suppl):S3-S11.
9. Webber MP, Carpiniello KE, Oruwariye T, Appel DK. Prevalence of asthma and asthma-like symptoms in inner-city elementary school children. Pediatr Pulmonol 2002;34:105-111.
10. Mannino DM, Homa DM, Pertowski CA, Ashizawa A, Nixon LL, Johnson CA, Ball LB, Jack E, Kang DS. Surveillance for asthma- United States, 1960-1995. MMWR CDC Serveill Summ 1998; 47:1-28.
11. Pesola GR, Xu F, Ashan H, Sternfeis P, Meyer I, Ford J. Predicting asthma morbidity in Harlem Emergency Department patients. Emer Med 2004; Sept II(9): 944-950.
12. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health 1992; 82:59-65.
13. De Palo VA, Mayo PH, Fiedman P, Rosen MJ. Demographic influences on asthma hospital admission rates in New York City. Chest 1994; 106:447-451.
14. Claudio L, Tulton L, Doucette J, Landrigan PJ. Socioeconomic factors and asthma hospitalization rates in New York City. J Asthma 1999; 36:343-350.